TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Frontage Holdings Corp. ( (HK:1521) ) has provided an announcement.
Frontage Holdings Corporation has updated the terms of reference for its Nomination Committee, which was originally established in 2018. The committee will consist of at least three non-executive directors, with a majority being independent and at least one member of a different gender, reflecting the company’s commitment to diversity and governance.
The most recent analyst rating on (HK:1521) stock is a Hold with a HK$1.57 price target. To see the full list of analyst forecasts on Frontage Holdings Corp. stock, see the HK:1521 Stock Forecast page.
More about Frontage Holdings Corp.
Frontage Holdings Corporation operates within the pharmaceutical and biotechnology industry, providing research and development services to support drug discovery and development processes.
Average Trading Volume: 270,962
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$2.3B
For a thorough assessment of 1521 stock, go to TipRanks’ Stock Analysis page.